Potential Corona-drug identified
Check an interview with Stefan Pöhlman, head of the Infection Biology Unit at the German Primate Center (DPZ) in Göttingen: https://www.youtube.com/watch?v=plhfUVtC_EU&feature=youtu.be.
Original publication:
Hoffmann, M. et al. (2020). “SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a 2 clinically-proven protease inhibitor.“ Cell. DOI: 10.1016/j.cell.2020.02.052